Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYPH
3251
Cypherpunk Technologies Inc
CYPH
$74.5M
| $102K | ﹤0.01% |
39,850
-57,820
| -59% | -$142K |
|
3252
Gray Media Inc
GTN.A
$679M
| $102K | ﹤0.01% |
14,700
-300
| -2% | -$2.48K |
|
3253
Yunhong Green CTI Ltd
YHGJ
$7.57M
| $102K | ﹤0.01% |
12,177
-220
| -2% | -$2.08K |
|
|
IOBT
3254
DELISTED
IO Biotech
IOBT
| $102K | ﹤0.01% |
97,000
-83,800
| -46% | -$106K |
|
|
MKFG
3255
DELISTED
Markforged Holding Corporation
MKFG
| $102K | ﹤0.01% |
21,339
+10,109
| +90% | +$32.8K |
|
|
DXYN
3256
DELISTED
Dixie Group Inc
DXYN
| $102K | ﹤0.01% |
145,300
+27,500
| +23% | +$19.5K |
|
|
YI
3257
111 Inc
YI
$31.4M
| $101K | ﹤0.01% |
13,425
+2,210
| +20% | +$20.3K |
|
|
BOLD
3258
Boundless Bio
BOLD
$64.7M
| $99.6K | ﹤0.01% |
28,700
-16,683
| -37% | -$60.5K |
|
3259
Nuvectis Pharma
NVCT
$635M
| $99.4K | ﹤0.01% |
15,800
-58,700
| -79% | -$386K |
|
3260
DarioHealth
DRIO
$68.2M
| $98.2K | ﹤0.01% |
4,385
-200
| -4% | -$4.05K |
|
|
INCR
3261
Intercure
INCR
$56.4M
| $98.1K | ﹤0.01% |
48,800
+3,500
| +8% | +$7.34K |
|
|
KNDI
3262
Kandi Technologies Group
KNDI
$68.8M
| $96.8K | ﹤0.01% |
47,000
-300
| -0.6% | -$545 |
|
3263
PepGen
PEPG
$133M
| $96.6K | ﹤0.01% |
11,300
-700
| -6% | -$8.28K |
|
3264
First Seacoast Bancorp
FSEA
$80.4M
| $95.5K | ﹤0.01% |
+10,532
| New | +$96.7K |
|
|
IPM
3265
Intelligent Protection Management Corp
IPM
$24M
| $95K | ﹤0.01% |
29,400
+4,400
| +18% | +$17K |
|
3266
PharmaCyte Biotech
PMCB
$6.33M
| $94.9K | ﹤0.01% |
49,700
+1,200
| +2% | +$2.23K |
|
3267
Gain Therapeutics
GANX
$76.4M
| $94.8K | ﹤0.01% |
53,264
-65,436
| -55% | -$82.2K |
|
3268
System1
SST
$15M
| $94.4K | ﹤0.01% |
8,430
+2,640
| +46% | +$33.9K |
|
|
IRD
3269
Opus Genetics
IRD
$297M
| $92.5K | ﹤0.01% |
70,609
+28,909
| +69% | +$44.5K |
|
3270
Arts-Way Manufacturing Co
ARTW
$11.4M
| $91.5K | ﹤0.01% |
49,448
+7,674
| +18% | +$12.9K |
|
|
CARV
3271
DELISTED
Carver Bancorp
CARV
| $91.4K | ﹤0.01% |
47,600
+1,900
| +4% | +$3.5K |
|
|
NXDT
3272
NexPoint Diversified Real Estate Trust
NXDT
$235M
| $91.2K | ﹤0.01% |
14,591
-117,472
| -89% | -$697K |
|
|
FURY
3273
Fury Gold Mines
FURY
$107M
| $90.3K | ﹤0.01% |
207,465
+4,468
| +2% | +$1.82K |
|
3274
Sprinklr
CXM
$1.55B
| $88.9K | ﹤0.01% |
11,500
-50,300
| -81% | -$443K |
|
3275
ProKidney
PROK
$337M
| $88.7K | ﹤0.01% |
+46,200
| New | +$105K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.